Mentioned in the company presentation, 22 November
Slide 8
New products and new category opportunities via alliances:
- breast reconstruction
- soft tissue reinforcement
- orthobiologics (bone, tendon, ligament repair)
- delivery of therapeutics (anti-microbials, drug elution, cell-based therapies)
Slide 9
- Alliances with global category leaders and academia for Clinical & Health-economics evidence
- Opportunity to enter breast reconstruction, soft tissue reinforcement, orthobiologics, delivery of therapeutics
Slide 12
Syntrel –
- Targeting the US$2.5bn hernia and abdominal wall reconstruction market via the Syntrel family of products, and currently evaluating several design options with key opinion leaders
- Developing modified NovoSorb products for soft tissue reinforcement
- Breast reconstruction development in-house
- Exploring alliances for Orthobiologics (bone, tendon, ligament regeneration)
- Investigating NovoSorb-based products for Type I diabetes and supplying NovoSorb to Beta-Cell Technologies (3rd party) for clinical trials
- Co-Development of Composite Cultured Skin for single-stage skin replacement
- NovoSorb Drug Elution Depot (pellet), involving the integration of drug treatment into the NovoSorb polymer
- Incorporation of anti-microbials into NovoSorb polymer for controlled release for infection management
It’s a bit unclear, but there definitely seems to be an intention to form alliances for development of orthobiologics (bone, tendon, ligament repair) and therapeutics delivery (anti-microbials, drug elution, cell-based therapies).
Non-academia alliances are expected to be with “global category leaders”.
- Forums
- ASX - By Stock
- Ann: Webcast Recording - Investor Presentation and Update
Mentioned in the company presentation, 22 November Slide 8 New...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.47 |
Change
0.120(5.11%) |
Mkt cap ! $1.706B |
Open | High | Low | Value | Volume |
$2.38 | $2.52 | $2.38 | $6.169M | 2.501M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3613 | $2.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.48 | 38844 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3613 | 2.470 |
5 | 33814 | 2.460 |
1 | 10982 | 2.450 |
4 | 35957 | 2.440 |
2 | 2518 | 2.430 |
Price($) | Vol. | No. |
---|---|---|
2.480 | 38844 | 1 |
2.490 | 2016 | 1 |
2.500 | 8018 | 5 |
2.510 | 38564 | 7 |
2.520 | 24437 | 6 |
Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |